NEW YORK (TheStreet) -- Catamaran (CTRX) shares are up 12.5% to $47.39 on Thursday after the pharmacy benefit management company reported third quarter earnings that beat analysts expectations for the period.
The company reported adjusted earnings of 58 cents per diluted share, 2 cents better than analysts were expecting for the period, and 6 cents better than the 52 cents it reported last year.
Revenue for the period rose 53.3% over the previous year to $5.54 billion, ahead of analysts' $5.35 billion estimates.
The company also raised its full year EPS guidance to between $2.20 to $2.25 from its previous expectations of between $2.12 and $2.22.
TheStreet Ratings team rates CATAMARAN CORP as a Buy with a ratings score of B-. TheStreet Ratings Team has this to say about their recommendation:
"We rate CATAMARAN CORP (CTRX) a BUY. This is driven by multiple strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and notable return on equity. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself."
Highlights from the analysis by TheStreet Ratings Team goes as follows:
- You can view the full analysis from the report here: CTRX Ratings Report